Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 184.82

-1.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (24940)	8/28/1998 6:38:00 AM
From: Henry Niman	Read Replies (1) of 32384

Yeterday's CNBC report on the pharmas was repeated this morning. The WSJ is running a story today on an upcoming presentation that will try to shift the heart valve problems attributed to Redux (dexfenflouramine) and Pondimen (fenflouramine) to phentermine (other half of fen/phen combo). Study was done by founder of IPIC (makers of Redux) and SBH is calling foul. Some have replaced redux with Prozac (LLY) and the report suggest that the since phentermine is a MOA inhibitor(as is Sudafed sold by WLA, and St John's Wart) many combinations may cause heart valve problems. The study is to be presented this weekend: paradise-web.com and could cause considerable concern if coverage is widespread.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next